Kenneth J. Hillan - 20 Nov 2022 Form 4 Insider Report for 23andMe Holding Co. (MEHCQ)

Role
Chief Therapeutics Officer
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Issuer symbol
MEHCQ
Transactions as of
20 Nov 2022
Net transactions value
-$13,838
Form type
4
Filing time
22 Nov 2022, 15:11:31 UTC
Previous filing
25 Aug 2022
Next filing
23 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A Common Stock Tax liability $13,838 -4,628 -2.3% $2.99 197,162 20 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The closing price on November 18, 2022, the fair market used for the transaction date.
F2 Includes 5,707 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on August 31, 2022.